Drug informationDrug withdrawal therapies, generalAdis Comments Acamprosate [ calcium acetylhomotaurinate ] is a GABAminergic compound that was originated by Meram for the treatment of alcohol dependence. Merck KGaA has licensed the compound. It has been launched in 25 countries. In most European ...
Acamprosate use while Breastfeeding (in more detail) Acamprosate Consumer Information Pregnancy Support Group FDA Pregnancy Categories Medicine use during Pregnancy Medicine use while Breastfeeding Safe Medications during BreastfeedingReferences for pregnancy information (2004) "Product Information. Campral (ac...
Acamprosate is a Food and Drug Administration (FDA) approved medication for the treatment of alcohol use disorder (AUD). However, only a subset of patients achieves optimal treatment outcomes. Currently, no biological measures are utilized to predict response to acamprosate treatment. We applied our...
Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies ...
Drug informationDrug withdrawal therapies, generalAdis Comments Acamprosate [calcium acetylhomotaurinate] is a GABAminergic compound that was originated by Meram for the treatment of alcohol dependence. Merck KGaA has licensed the compound. It...
In addition to these results the data set of the study was further analysed to get information about several clinical and research issues, e.g. if there are predictors for the positive outcome to this treatment, how the ideal patient for this treatment can be defined, whether measuring of ...
The latter was approved by the FDA in 2004.Objective:This article describes the pharmacologic properties and clinical usefulness of acamprosate for the treatment of alcohol dependence.Methods:Relevant information was identified through searches of MEDLINE (1966 to March 2005), International Pharmaceutical ...
The article presents information on acamprosate calcium, a new drug for alcohol dependence. In the U.S. an estimated 18 million people have problems related to alcohol dependence, contributing to many health problems and causing more than 100,000 deaths each year. Acamprosate has been indicated ...
Question Is acamprosate better then placebo or other drugs for reducing return to drinking and increasing duration of abstinence in patients with alcohol dependence? Review scope Included studies compared acamprosate, alone or combined with other therapies, with placebo or other drugs given for >4 ...
Methods: ADR information was gathered through personal interviews with patients or their relatives. Causality was assessed using the Naranjo algorithm, and a modified Hartwig and Siegel Severity Assessment Scale was used for estimating the severity of ADR. ADRs were grouped into various preventability ...